Page 762 - medicina-integrativa_compress

CAPÍTULO 72 DERMATITIS SEBORREICA 777

BIBLIOGRAFÍA 12. Schreiner AW, Rockwell E, Vilter RW: A local defect in the
metabolism of pyridoxine in the skin of persons with seborrheic
1. Bergbrant IM: Seborrheic dermatitis and Pityrosporum yeasts. dermatitis of the “sicca” type. J Invest Dermatol 19:95-96, 1952.
Curr Top Med Mycol 6:95-112, 1995. 13. Effersoe H: The effect of topical application of pyridoxine ointment
2. Watanabe S, Kano R, Sato H, et al: The effects of Malassezia yeasts on the rate of sebaceous secretion in patients with seborrheic
on cytokine production by human keratinocytes. J Invest Dermatol dermatitis. Acta Derm Venereol 3:272-278, 1954.
116:769-773, 2001. 14. Schulpis KH, Georgala S, Papakonstantinou ED, et al: The effect
3. Baroni A, Orlando M, Donnarumma G, et al: Toll-like receptor 2 of isotretinoin on biotinidase activity. Skin Pharmacol Appl Skin
(TLR2) mediates intracellular signalling in human keratinocytes in Physiol 12:28-33, 1999.
response to Malassezia furfur. Arch Dermatol Res 10:1-9, 15. Callaghan TJ: The effect of folic acid on seborrheic dermatitis.
2005. Cutis 3:583-588, 1967.
4. Senff H, Bothe C, Busacker J, Reinel D: Studies on the yeast flora 16. Andrews GC, Post CF, Domnkos AN: Seborrheic dermatitis:
in patients suffering from psoriasis capillitii or seborrheic dermatitis Supplemental treatment with vitamin B 12. N Y State Med J
of the scalp. Mycoses 33:29-32, 1990. 50:1921-1925, 1950.
5. Buslau M, Hanel H, Holzmann H: [The significance of yeasts in 17. Gupta AK, Nicol K, Batra R: Role of antifungal agents in the
seborrheic eczema]. Hautarzt 40:611-613, 1989. treatment of seborrheic dermatitis. Am J Clin Dermatol 5:417-422,
6. Dattner AM, Levis WR: Clonal priming of human lymphocytes with 2004.
soluble microbial antigens: High-dose paralysis, restoration, and 18. Vardy DA, Cohen AD, Tchetov T, et al: A double-blind, placebo-
autologous leukocyte preference. Scand J Immunol 8:403-412, 1978. controlled trial of an Aloe vera (A. barbadensis) emulsion in the
7. Albert LJ, Inman RD: Molecular mimicry and autoimmunity. N treatment of seborrheic dermatitis. J Dermatol Treat 10:7-11,
Engl J Med 341:2068-2074, 1999. 1999.
8. Lintu P, Savolainen J, Kalimo K, et al: Cross-reacting IgE and IgG 19. Maietta G, Fornaro P, Rongioletti F, Rebora A: Patients with mood
antibodies to Pityrosporum ovale mannan and other yeasts in atopic depression have a high prevalence of seborrheic dermatitis. Acta
dermatitis. Allergy 54:1067-1073, 1999. Derm Venereol 70:432-434, 1990.
9. Huang X, Johansson SG, Zargari A, Nordvall SL: Allergen 20. Maietta G, Rongioletti F, Rebora A: Seborrheic dermatitis and
cross-reactivity between Pityrosporum orbiculare and Candida daylight. Acta Derm Venereol 71:538-539, 1991.
albicans. Allergy 50:648-656, 1995. 21. Nenoff P, Haustein UF, Munzberger C: In vitro activity of lithium
10. Schena D, Chieregato GC, de Gironcoli M, et al: Increased succinate against Malassezia furfur. Dermatology 190:48-50, 1995.
erythrocyte membrane arachidonate and platelet malondialdehyde 22. Dreno B, Chosidow O, Revuz J, Moyse D: Lithium gluconate
(MDA) production in psoriasis: Normalization after fish-oil. Acta 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis:
Derm Venereol Suppl (Stockh) 146:42-44, 1989. A multicentre, randomized study. Br J Dermatol 148:1230-1236,
11. Sears B: Personal communication, 2001. 2003.

© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.